Schizophrenia develops from a combination of brain chemistry, genetics, and life stress—not from a single cause

No single thing causes schizophrenia. Instead, the condition appears when several factors line up: inherited vulnerability, differences in how the brain processes dopamine and other chemicals, and often a period of significant stress or trauma. Researchers have identified patterns, but they cannot yet predict who will develop schizophrenia or prevent it with certainty. Understanding what is known—and what remains unknown—matters because it shapes how the condition is treated and how people think about it.

The strongest evidence points to brain chemistry. People with schizophrenia show differences in dopamine signaling, a neurotransmitter that helps regulate thought, motivation, and emotion. Some antipsychotic medications work by adjusting dopamine levels, which suggests dopamine plays a real role. But dopamine is not the whole story. Other neurotransmitters—glutamate, serotonin, GABA—also appear involved, and the brain regions that control these chemicals do not work in isolation.

Key Takeaways

  • Schizophrenia is not caused by parenting, trauma alone, or personal weakness; it involves inherited brain differences and chemical imbalances.
  • Having a close relative with schizophrenia increases risk, but most people with a family history never develop the condition.
  • Environmental stressors—poverty, discrimination, drug use, major life disruption—can trigger schizophrenia in people who are already vulnerable.
  • Brain imaging shows structural and functional differences in people with schizophrenia, but these differences vary widely and do not predict the condition reliably.
  • Onset typically occurs in late adolescence or early adulthood, when the brain is still developing, suggesting developmental timing matters.

Genetics and family history

Schizophrenia runs in families, but not in a straightforward way. If one parent has schizophrenia, a child has roughly a 10 to 15 percent chance of developing it—higher than the general population risk of about 1 percent, but still a minority. If both parents have schizophrenia, the risk rises to around 40 to 50 percent. If a sibling has it, risk is similar to having one affected parent.

This pattern shows genetic influence without genetic certainty. Researchers have identified dozens of genetic variations linked to schizophrenia risk, but no single gene causes it. Instead, many genes contribute small amounts of risk, and the combination matters more than any one variant. A person can inherit all the genetic risk factors and never develop schizophrenia if other conditions are not met. Conversely, someone with minimal genetic risk can develop it if environmental stress is severe enough.

Identical twins—who share 100 percent of DNA—show concordance rates around 40 to 50 percent, meaning if one twin has schizophrenia, the other has roughly a 50-50 chance. This proves that genes alone do not determine the outcome. Something else must tip the balance.

Brain chemistry and neurotransmitter systems

The dopamine hypothesis emerged in the 1960s and remains central to understanding schizophrenia, though it has evolved. The original idea was simple: too much dopamine causes psychosis. Antipsychotic drugs block dopamine receptors, and they reduce hallucinations and delusions in many people, which seemed to confirm the theory. But the reality is more complex.

Current research suggests the problem is not uniform dopamine excess but rather dysregulation—dopamine is too high in some brain regions (the limbic system, which processes emotion and reward) and too low in others (the prefrontal cortex, which handles planning and reasoning). This imbalance may explain why people with schizophrenia experience both positive symptoms like hallucinations and negative symptoms like reduced motivation and emotional flatness.

Glutamate, the brain's main excitatory neurotransmitter, also appears disrupted. Some researchers believe glutamate signaling is abnormally low in schizophrenia, which could explain cognitive symptoms. This is why experimental treatments targeting glutamate are being studied. Serotonin, GABA, and other chemical messengers also show abnormalities in people with schizophrenia, suggesting the condition involves multiple overlapping chemical imbalances rather than one broken system.

Brain structure and development

Brain imaging studies reveal that people with schizophrenia often have subtle structural differences compared to people without the condition. Some show enlarged ventricles (fluid-filled spaces in the brain), reduced gray matter volume in certain regions, or altered white matter (the connections between brain regions). The prefrontal cortex and temporal lobes are frequently affected.

These differences are real but variable. Not every person with schizophrenia shows the same pattern, and some show no obvious structural change on imaging. This means brain structure alone cannot diagnose schizophrenia or predict who will develop it. The differences may reflect how the brain developed before symptoms appeared, or they may result from the condition itself or from medication effects over time.

Timing matters. The brain undergoes major reorganization during adolescence and early adulthood—a period when synapses are pruned, white matter is refined, and the prefrontal cortex continues maturing. Schizophrenia typically emerges during this window, suggesting that disruption to normal developmental processes plays a role. Whether the disruption is genetic, environmental, or both remains unclear.

Environmental and life stressors

Genetics loads the gun, but environment may pull the trigger. People with genetic vulnerability to schizophrenia are more likely to develop it if they experience significant stress. Documented stressors include childhood trauma or abuse, major loss, social isolation, discrimination, poverty, and urban living (which carries higher schizophrenia rates than rural areas). Cannabis use, especially heavy use during adolescence, is associated with earlier onset and worse outcomes in people at genetic risk.

The stress-vulnerability model proposes that schizophrenia emerges when environmental demands exceed a person's coping capacity—and that capacity is partly determined by genetics. A person with high genetic risk might develop schizophrenia after moderate stress, while someone with low genetic risk might need extreme stress to trigger it, or might never develop it at all.

Prenatal factors also matter. Maternal infection during pregnancy, nutritional deficiency, or complications at birth are associated with increased schizophrenia risk in offspring. These factors may disrupt normal brain development in ways that increase vulnerability later.

Why onset typically occurs in late teens and early adulthood

Schizophrenia rarely appears before age 12 and is uncommon after age 40. The peak onset is between ages 16 and 30, with men typically developing it slightly earlier than women. This narrow window suggests that something about brain development during adolescence and early adulthood is critical.

The adolescent brain undergoes pruning—a process where unused neural connections are eliminated and remaining ones are strengthened. This refinement is necessary for mature thinking but may also create vulnerability. If the pruning process is disrupted or excessive, or if dopamine systems are not properly calibrated during this period, psychosis may emerge. Stress during this developmental window may be more damaging than stress at other ages.

Why some people develop schizophrenia at 18 and others at 35, despite similar genetic and environmental risk, remains unexplained. Individual variation in brain development timing, hormone levels, and life circumstances all likely play a role.

What does not cause schizophrenia

Decades of research have ruled out several once-common beliefs. Schizophrenia is not caused by bad parenting, though family stress can worsen symptoms. It is not caused by personal weakness, moral failure, or lack of willpower. It is not contagious, and it is not a punishment. Trauma alone does not cause schizophrenia, though trauma in a genetically vulnerable person may contribute to onset.

These clarifications matter because stigma often rests on false ideas about causation. If schizophrenia were a choice or a character flaw, blame would be appropriate. But it is a medical condition rooted in biology, even though the full picture of how biology, genetics, and environment interact remains incomplete.

Frequently Asked Questions

If my parent has schizophrenia, will I definitely develop it?

No. Having a parent with schizophrenia increases your risk to roughly 10 to 15 percent, compared to 1 percent in the general population. That means 85 to 90 percent of people with an affected parent never develop schizophrenia. Risk is higher than average, but most people with family history remain unaffected.

Can cannabis use cause schizophrenia?

Cannabis use is associated with earlier onset and worse outcomes in people who are genetically vulnerable, especially if use begins in adolescence. But cannabis alone does not cause schizophrenia in people without genetic risk. The relationship is complex: vulnerability plus cannabis use plus other stressors may combine to trigger the condition.

Does schizophrenia run in families on only one side?

Schizophrenia can appear on either side of the family or both. Risk comes from both maternal and paternal relatives. Having multiple affected relatives increases risk more than having one affected relative, but the inheritance pattern is not predictable.

Can stress alone cause schizophrenia?

Stress alone typically does not cause schizophrenia in people without genetic vulnerability. But in people who are genetically at risk, significant stress—trauma, major loss, discrimination, or sustained hardship—can trigger onset. The combination of genetic predisposition and environmental stress matters more than either factor alone.

Why does schizophrenia usually start in the late teens or twenties?

The adolescent brain undergoes major reorganization, including pruning of neural connections and maturation of dopamine systems. This developmental window appears to create vulnerability. Stress during this period may be more likely to trigger psychosis in genetically vulnerable people than stress at other ages.